| CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma J Cano-Mejia, A Shukla, DK Ledezma, E Palmer, A Villagra, R Fernandes Translational Oncology 13 (10), 100823, 2020 | 38 | 2020 |
| Indocyanine green-nexturastat A-PLGA nanoparticles combine photothermal and epigenetic therapy for melanoma DK Ledezma, PB Balakrishnan, J Cano-Mejia, EE Sweeney, M Hadley, ... Nanomaterials 10 (1), 161, 2020 | 26 | 2020 |
| CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma PB Balakrishnan, DK Ledezma, J Cano-Mejia, J Andricovich, E Palmer, ... Nano research, 1-15, 2022 | 20 | 2022 |
| Anti-Fn14-conjugated Prussian blue nanoparticles as a targeted photothermal therapy agent for glioblastoma NF Bonan, DK Ledezma, MA Tovar, PB Balakrishnan, R Fernandes Nanomaterials 12 (15), 2645, 2022 | 10 | 2022 |
| The thermal dose of photothermal therapy generates differential immunogenicity in human neuroblastoma cells P Sekhri, DK Ledezma, A Shukla, EE Sweeney, R Fernandes Cancers 14 (6), 1447, 2022 | 10 | 2022 |
| Interstitial photothermal therapy generates durable treatment responses in neuroblastoma DK Ledezma, PB Balakrishnan, A Shukla, JA Medina, J Chen, E Oakley, ... Advanced healthcare materials 11 (20), 2201084, 2022 | 9 | 2022 |
| Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity JA Medina, DK Ledezma, J Ghofrani, J Chen, SJ Chin, PB Balakrishnan, ... Nanomedicine 19 (25), 2049-2064, 2024 | | 2024 |
| PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent PB Balakrishnan, CS Holmberg, DK Ledezma, A Bosque, R Fernandes Nanomedicine 17 (29), 2159-2171, 2022 | | 2022 |
| Combined Nanoparticle-based Photothermal Therapy and Epigenetic Immunomodulation for Melanoma D Ledezma, R Fernandes | | 2019 |
